MedPath

Salvage local ablation therapy for radiation-recurrent prostate cancer

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-jRCTs052180227
Lead Sponsor
kimura Osamu
Brief Summary

one was enrolled in this research period.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
0
Inclusion Criteria

1) Patients with relapsed prostate cancer who have received radiation therapy
2) Patients whose initial clinical stage was T1N0 or T2N0
3) Serum PSA level less than 10ng/ml
4) Age more than 20 years old (at the time of consent for the study)

Exclusion Criteria

1) Ptients with active urinary tract infection such as cystitis, prostatitis and urethraitis)
2) Patients with prostate cancer who have metastasis
3) Patietns with prostate stone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath